Why is Boston Bio falling/rising?

As of 26-Jun, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.96, which reflects a decrease of 0.16 or 1.97%. The stock has underperformed its sector by 1.56% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of 3.86% during this period. Additionally, the stock has shown erratic trading patterns, having not traded on one day out of the last 20 days. The delivery volume has significantly decreased by 98.85% against the 5-day average, indicating a drop in investor participation. While the stock is trading higher than its 20-day and 50-day moving averages, it is below the 5-day, 100-day, and 200-day moving averages, suggesting a weakening momentum. There are no positive or negative factors available to further explain the stock's recent movement.
In the broader market context, Boston Bio's performance over the past week shows a decline of 7.55%, while the benchmark Sensex has increased by 2.94%, highlighting a significant underperformance relative to the market. Over the past month, however, the stock has gained 9.19%, outperforming the Sensex, which rose by 1.92%. This indicates that while the stock has had a strong month, its recent short-term performance has been poor compared to the overall market, contributing to the current decline in price.